Skip to content

Drug interactions

Glyburide-metformin + Lasmiditan

Severity: Minor

Glyburide-metformin and Lasmiditan: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lasmiditan inhibits BCRP in vitro, and glyburide is a BCRP substrate, so glyburide exposure could increase. The clinical relevance is uncertain, but it could heighten hypoglycemia risk.

What this interaction means in plain words

Glyburide-metformin and Lasmiditan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Glyburide-metformin belongs to Endocrine; Lasmiditan belongs to Central Nervous System.

Evidence level: Low

Why it happens

Lasmiditan may inhibit intestinal BCRP efflux of glyburide, based on in vitro data.

What to do

No routine change is needed. Advise patients to report symptoms of hypoglycemia and check glucose if they occur.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Glyburide-metformin and Lasmiditan, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Glyburide-metformin with Lasmiditan?

MediHelp rates the interaction as minor. Glyburide-metformin and Lasmiditan have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Lasmiditan inhibits BCRP in vitro, and glyburide is a BCRP substrate, so glyburide exposure could increase. The clinical relevance is uncertain, but it could heighten hypoglycemia risk.

How serious is the interaction between Glyburide-metformin and Lasmiditan?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine change is needed. Advise patients to report symptoms of hypoglycemia and check glucose if they occur.

What other medicines interact with Glyburide-metformin?

MediHelp also lists interactions of Glyburide-metformin with, for example, Bosentan, Cholic acid, Clarithromycin. The full list is on the Glyburide-metformin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in